To the Editor: Erythrocytapheresis is an established therapy for the prevention of stroke in sickle cell disease [1]. We report its use in the prevention of recurrent acute coronary syndromes. A 50-year-old woman, with homozygous sickle cell disease presented in December 2005 with central chest pai
Zinc in the treatment of homozygous sickle cell anemia: Studies in an animal model
β Scribed by Eric B. Schoomaker; George J. Brewer; Fred J. Oelshlegel Jr.
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- English
- Weight
- 729 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We perfornied exchange transfusions. utilizing the technique of automated crythrocytaphcresk. for the treatment of patients with sickle cell anemia. In an attempt to determine guideline5 for the use of erythrocytapheresis, we studied the use of this procedure i n three distinct clinical situations i
## Abstract The in vitro synthesis of hemoglobin chains was investigated in 34 scikle cell anemia (SS) patients and five patients with Hb SβΞ²^o^βthalassemia. Incubations were made for 30 minutes and for 120 minutes. Hematological and family data were also obtained. Although the 30βminute Ξ±/nonβΞ± to
## Abstract External fixation is the current standard treatment for skeletal stabilization of open tibial fractures, but intramedullary fixation techniques have become increasingly popular. The aim of this study was to compare, in an animal model, the susceptibility to infection of contaminated fra
## Abstract Alkaptonuria (AKU) is a rare autosomal recessive disease, associated with deficiency of homogentisate 1,2βdioxygenase activity in the liver. This leads to an accumulation of homogentisic acid (HGA) and its oxidized derivatives in polymerized form in connective tissues especially in join